Innovating Works
TrojanDC: TrojanDC - A BREAKTHROUGH DEEP-TECH INNOVATION FOR CANCER IMMUNOTHERAPY ASGARD THERAPEUTICS AB tramitó un HORIZON EUROPE: HORIZON-EIE-2022-SCALEUP-02 The Challenge: Cancer remains one of the major challenges to modern medicine affecting one-in-three people in Europe. Available immunotherap...
2023-06-02 - 2024-06-30 | Financiado
TrojanDC: TrojanDC ASGARD THERAPEUTICS AB tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Asgard Therapeutics, a Swedish start-up company, was founded based on a unique proprietary in vivo cell reprogramming technology. This parad...
2019-11-15 - 2020-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.